PrepSolution

Nursing · Study journal

FNP GI and Renal Practice Questions: Hepatitis, GERD and CKD

Thirteen original FNP GI and renal questions on hepatitis B and C, colorectal screening, ACG GERD rules, PPI and nitrofurantoin label warnings, and ADA 2026 kidney care.

By Elena R.Published Reviewed by PrepSolution Editorial Team10 min read
Inside this articleNursing
Section preview 01

Hepatitis and colorectal screening

A 41-year-old with no known risk factors has never been tested for hepatitis C. What does USPSTF recommend?

Read this section
On this page

GI and renal items on the FNP boards test interpretation more than memorization: a hepatitis B panel, a urine albumin result, a symptom list that decides between a drug trial and a scope. Each question below gives you a result or a presentation and asks what the source says to do next.

The set is written for candidates using FNP-C exam prep. Diagnose and Plan together make up 54% of scored items on the NPCB blueprint, and this set leans on both. The AANP FNP exam blueprint guide lists every domain and age group with its share.

This set is exam practice written from the guidelines, USPSTF recommendations and FDA labels listed under References. The questions are original PrepSolution items, not NPCB or ANCC exam questions. It is not clinical guidance for any patient, and it has not been reviewed by a credentialed nurse practitioner.

Hepatitis and colorectal screening

Question 1: Hepatitis C screening age

A 41-year-old with no known risk factors has never been tested for hepatitis C. What does USPSTF recommend?

  • A. Screen only if he has injected drugs
  • B. Screen for HCV infection, since he is between 18 and 79
  • C. Screen only if liver enzymes are elevated
  • D. Screening is not recommended before 50

Best answer: B. USPSTF recommends screening for HCV infection in all adults aged 18 to 79, not only those with risk factors. Grade B.

  • A is not the best answer. The recommendation covers all adults in the age range, not only people with risk factors.
  • C is not the best answer. Screening does not depend on abnormal liver enzymes.
  • D is not the best answer. The age range begins at 18.

Question 2: Reading a hepatitis B panel: acute infection

A 33-year-old with fatigue and jaundice has HBsAg positive, total anti-HBc positive, IgM anti-HBc positive, and anti-HBs negative. What does CDC say this pattern means?

  • A. Resolved infection
  • B. Immunity from vaccination
  • C. Chronic infection
  • D. Acute infection

Best answer: D. CDC interprets HBsAg positive, total anti-HBc positive, IgM anti-HBc positive and anti-HBs negative as acute infection, with linkage to hepatitis B care. IgM anti-HBc positivity points to recent infection.

  • A is not the best answer. Resolved infection has a negative HBsAg and a positive anti-HBs.
  • B is not the best answer. Vaccine immunity shows anti-HBs alone, with negative HBsAg and anti-HBc.
  • C is not the best answer. Chronic infection has a negative IgM anti-HBc.

Question 3: Reading a hepatitis B panel: past infection

A 58-year-old has HBsAg negative, total anti-HBc positive and anti-HBs positive. What does CDC say this means, and what is the action?

  • A. Resolved infection; counsel about reactivation risk
  • B. Acute infection; link to hepatitis B care
  • C. Susceptible; give the vaccine series
  • D. Immunity from vaccination only; no counseling needed

Best answer: A. CDC reads HBsAg negative, total anti-HBc positive and anti-HBs positive as resolved infection, and the listed action is to counsel about HBV reactivation risk.

  • B is not the best answer. Acute infection requires a positive HBsAg and IgM anti-HBc.
  • C is not the best answer. A positive anti-HBs means the patient is not susceptible.
  • D is not the best answer. A positive anti-HBc shows past infection, which vaccination alone does not produce.

Question 4: Reading a hepatitis B panel: vaccinated

A 25-year-old nursing student with a documented complete hepatitis B vaccine series has HBsAg negative, total anti-HBc negative and anti-HBs positive. What does this pattern mean?

  • A. Chronic infection
  • B. Occult infection
  • C. Immune from prior vaccination
  • D. Susceptible, never infected

Best answer: C. CDC interprets HBsAg negative, total anti-HBc negative and anti-HBs positive as immune from prior vaccination, when a complete series is documented.

  • A is not the best answer. Chronic infection requires a positive HBsAg.
  • B is not the best answer. Occult infection is one interpretation of an isolated positive anti-HBc, which this patient does not have.
  • D is not the best answer. A positive anti-HBs means she is not susceptible.

Question 5: Colorectal screening start age

A healthy 45-year-old at average risk asks when to start colorectal cancer screening. What does USPSTF recommend?

  • A. Start at 50
  • B. Start only with a family history
  • C. Start at 55 for men
  • D. Start now; USPSTF recommends screening adults 45 to 49

Best answer: D. USPSTF recommends colorectal cancer screening in adults aged 45 to 49 (Grade B) and in all adults 50 to 75 (Grade A). For 76 to 85 it recommends selectively offering screening.

  • A is not the best answer. Age 50 was the older start age; USPSTF now starts at 45.
  • B is not the best answer. The recommendation applies to average-risk adults.
  • C is not the best answer. The start age is the same for men and women.

GERD

Question 6: Classic heartburn without alarm symptoms

A 44-year-old has heartburn and regurgitation several times a week. She has no dysphagia, weight loss or bleeding. What does the ACG guideline recommend first?

  • A. Upper endoscopy before any treatment
  • B. An 8-week trial of a PPI once daily before a meal
  • C. A barium swallow
  • D. Twice-daily PPI for 6 months

Best answer: B. For classic GERD symptoms of heartburn and regurgitation without alarm symptoms, ACG recommends an 8-week trial of empiric PPI once daily before a meal (strong recommendation).

  • A is not the best answer. Endoscopy first is for dysphagia or other alarm symptoms, or multiple Barrett's risk factors.
  • C is not the best answer. ACG does not recommend a barium swallow as the only diagnostic test for GERD.
  • D is not the best answer. The initial trial is once daily for 8 weeks.

Question 7: When to take the PPI

A patient on omeprazole for GERD takes it at bedtime and still has daytime symptoms. What does ACG recommend about timing?

  • A. Take it with the largest meal
  • B. Take it at bedtime with a snack
  • C. Take it 30 to 60 minutes before a meal
  • D. Timing does not matter

Best answer: C. ACG recommends PPI administration 30 to 60 minutes before a meal rather than at bedtime for GERD symptom control (strong recommendation).

  • A is not the best answer. The recommendation is before a meal, not with it.
  • B is not the best answer. Bedtime dosing is what ACG recommends against in favor of pre-meal dosing.
  • D is not the best answer. ACG makes a specific timing recommendation.

Question 8: Reflux with trouble swallowing

A 63-year-old with years of heartburn now has difficulty swallowing solids and has lost weight. What does ACG recommend?

  • A. Endoscopy as the first test
  • B. An 8-week empiric PPI trial
  • C. Add an H2 blocker at night
  • D. Reassure and recheck in 6 months

Best answer: A. ACG recommends endoscopy as the first test for patients with dysphagia or other alarm symptoms such as weight loss and GI bleeding.

  • B is not the best answer. The empiric PPI trial is for classic symptoms without alarm features.
  • C is not the best answer. Adding an H2 blocker treats symptoms and skips the evaluation ACG recommends.
  • D is not the best answer. Alarm symptoms call for evaluation now.

Question 9: Long-term PPI and vitamin B12

A 74-year-old has taken omeprazole daily for 5 years. Which label warning relates to the duration of use?

  • A. Weight gain
  • B. Hyperkalemia
  • C. Elevated LDL cholesterol
  • D. Daily use longer than about 3 years may lead to vitamin B12 deficiency

Best answer: D. The Prilosec label warns that daily long-term use, for example longer than 3 years, may lead to malabsorption or a deficiency of cyanocobalamin (vitamin B12). The label also lists C. difficile-associated diarrhea and hypomagnesemia with prolonged treatment.

  • A is not the best answer. Weight gain is not a labeled warning tied to duration.
  • B is not the best answer. Hyperkalemia is not a labeled PPI warning.
  • C is not the best answer. LDL is not a labeled PPI warning.

Urinary tract and kidney

Question 10: Bacteria in the urine without symptoms

A 70-year-old woman without urinary symptoms asks for a routine urine culture. She is not pregnant. What does USPSTF recommend?

  • A. Screen yearly with urine culture
  • B. Recommend against screening for asymptomatic bacteriuria in nonpregnant adults
  • C. Screen with dipstick every visit
  • D. Screen only after age 75

Best answer: B. USPSTF recommends against screening for asymptomatic bacteriuria in nonpregnant adults (Grade D). Screening with urine culture is recommended in pregnant persons.

  • A is not the best answer. Routine screening is what USPSTF recommends against in nonpregnant adults.
  • C is not the best answer. Changing the test does not change the recommendation.
  • D is not the best answer. There is no age at which USPSTF recommends screening nonpregnant adults.

Question 11: Nitrofurantoin and kidney function

A 79-year-old woman with cystitis has a creatinine clearance of 42 mL/min. Why is nitrofurantoin a poor choice, per its label?

  • A. It is contraindicated only in men
  • B. It is ineffective against E. coli
  • C. Significant renal impairment, defined as creatinine clearance under 60 mL/min, is a contraindication
  • D. It must be given intravenously in older adults

Best answer: C. The Macrobid label lists anuria, oliguria, or significant impairment of renal function, defined as creatinine clearance under 60 mL/min or clinically significant elevated serum creatinine, as contraindications, because impaired excretion raises the risk of toxicity.

  • A is not the best answer. The contraindication is renal, not sex-based.
  • B is not the best answer. The contraindication is about toxicity from impaired excretion, not drug spectrum.
  • D is not the best answer. Macrobid is an oral capsule.

Question 12: Confirming albuminuria

A 55-year-old with type 2 diabetes has a single urine albumin-to-creatinine ratio of 48 mg/g. What does ADA 2026 say is needed before calling this albuminuria?

  • A. Two of three UACR specimens collected within 3 to 6 months should be abnormal
  • B. Nothing; one UACR of 30 mg/g or more is diagnostic
  • C. A 24-hour urine protein in every case
  • D. A kidney biopsy

Best answer: A. Because urinary albumin varies by more than 20% between measurements, ADA states that two of three UACR specimens collected within a 3- to 6-month period should be abnormal before calling albuminuria moderately or severely elevated. Exercise, infection, fever and marked hyperglycemia can raise a single result.

  • B is not the best answer. One result is not enough because of high biological variability.
  • C is not the best answer. ADA uses spot UACR, not a mandatory 24-hour collection.
  • D is not the best answer. Biopsy is not part of confirming albuminuria.

Question 13: Diabetes with CKD

A 66-year-old with type 2 diabetes and CKD has an eGFR of 34 mL/min/1.73 m2. What does ADA 2026 recommend to slow CKD progression and reduce cardiovascular events?

  • A. Avoid SGLT2 inhibitors below an eGFR of 45
  • B. Use an SGLT2 inhibitor only if A1C is above 8%
  • C. Stop all diabetes medicines until eGFR is rechecked
  • D. An SGLT2 inhibitor with demonstrated benefit, started when eGFR is 20 or above

Best answer: D. ADA recommends an SGLT2 inhibitor with demonstrated benefit to reduce CKD progression and cardiovascular events in type 2 diabetes with CKD. It should be started when eGFR is 20 mL/min/1.73 m2 or above and can continue until kidney failure.

  • A is not the best answer. ADA sets the start threshold at an eGFR of 20, not 45.
  • B is not the best answer. The kidney and heart benefit is independent of glucose lowering.
  • C is not the best answer. Stopping therapy is not part of the recommendation.

Hepatitis B patterns at a glance

HBsAgTotal anti-HBcAnti-HBsCDC interpretation
PositivePositive (IgM positive)NegativeAcute infection
PositivePositive (IgM negative)NegativeChronic infection
NegativePositivePositiveResolved infection
NegativeNegativePositiveImmune from vaccination (documented series)
NegativeNegativeNegativeSusceptible, never infected
CDC interpretation of the hepatitis B triple panel, as used in this set.

How should you use this set?

For the serology items, read HBsAg first (infected now or not), then anti-HBc (ever infected), then anti-HBs (immune). For GERD, sort the presentation into classic symptoms or alarm symptoms before choosing a test or a drug. For kidney items, check whether the number in the stem is a single result or a confirmed one. Lifestyle steps from the same ACG guideline, such as raising the head of the bed for nighttime symptoms, are worth knowing too.

Drug-safety rules from other systems are in our FNP pharmacology practice set, and pregnancy-related urinary screening is covered in the women's health set. Timed practice for the whole blueprint is part of FNP-C exam prep.

Elena R.

PrepSolution Content Editor, Nurse Practitioner Certification

About PrepSolution

References

  1. [1] USPSTF (2020). Hepatitis C Virus Infection in Adolescents and Adults: Screening. USPSTF. USPSTF
  2. [2] USPSTF (2021). Colorectal Cancer: Screening. USPSTF. USPSTF
  3. [3] USPSTF (2019). Asymptomatic Bacteriuria in Adults: Screening. USPSTF. USPSTF
  4. [4] CDC (2026). Clinical Testing and Diagnosis for Hepatitis B. CDC. CDC
  5. [5] ACG (2022). Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. ACG. ACG
  6. [6] ADA (2026). 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes 2026. ADA. ADA
  7. [7] FDA label (2026). Prilosec (omeprazole magnesium). FDA label. FDA label
  8. [8] FDA label (2026). Macrobid (nitrofurantoin monohydrate/macrocrystals). FDA label. FDA label
  9. [9] NPCB (2026). FNP Candidate Handbook (June 2026). NPCB. NPCB

Help us improve this guide

How helpful was this article?

One tap helps us understand what’s useful.

Not helpful → Very helpful

Frequently asked questions

USPSTF recommends screening all adults aged 18 to 79 (Grade B).

With negative HBsAg and anti-HBc and a documented vaccine series, CDC reads it as immunity from vaccination.

ACG recommends an 8-week trial of a PPI once daily, taken 30 to 60 minutes before a meal.

ACG recommends endoscopy first for dysphagia or other alarm symptoms such as weight loss and GI bleeding, and for patients with multiple risk factors for Barrett's esophagus.

The Macrobid label lists creatinine clearance under 60 mL/min as a contraindication.

No. They are original PrepSolution items written from the sources listed under References. They are not clinical guidance and have not been reviewed by a credentialed nurse practitioner.

Keep practicing for the FNP-C.

Review the study tools, access options and price, or start with free practice.

Related Articles